Serelaxin improves the therapeutic efficacy of RXFP1-expressing human amnion epithelial cells in experimental allergic airway disease

Clinical Science

Volumn 130, Issue 23, 2016, Pages 2151-2165

  Royce, Simon G ^a   Tominaga, Anna M ^a   Shen, Matthew ^a   Pate, Krupesh P ^a   Huuskes, Brooke M ^a   Lim, Rebecca ^a   Ricardo, Sharon D ^a   Samue, Chrishan S ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Airway remodelling; Asthma; Fibrosis; Serelaxin; Stem cells

Indexed keywords

COLLAGEN; OVALBUMIN; RECEPTOR; RELAXIN; RELAXIN FAMILY PEPTIDE RECEPTOR 1; SERELAXIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; RLN2 PROTEIN, HUMAN; RXFP1 PROTEIN, HUMAN;

ALLERGIC DISEASE; AMNION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CONTROLLED STUDY; EPITHELIUM CELL; EXPERIMENTAL ALLERGIC AIRWAY DISEASE; EXPERIMENTAL DISEASE; EXTRACELLULAR MATRIX; FEMALE; FIBROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; STEM CELL; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; CYTOLOGY; DISEASE MODEL; GENETICS; IMMUNOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; TRANSPLANTATION;

AMNION; ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RELAXIN;

EID: 85014396575     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20160328     Document Type: Article

References (59)

1. Levy, M.L., Fletcher, M., Price, D.B., Hausen, T., Halbert, R.J. and Yawn, B.P. (2006) International primary care respiratory group (IPCRG) guidelines: diagnosis of respiratory diseases in primary care. Prim. Care Respir. J. 15, 20-34.
2. Myers, T.R. and Tomasio, L. (2011) Asthma: 2015 and beyond. Respir. Care 56, 1389-1407.
3. To, T., Stanojevic, S., Moores, G., Gershon, A.S., Bateman, E.D., Cruz, A.A. and Boulet, L.P. (2012) Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health 12, 204.
4. Braman, S.S. (2006) The global burden of asthma. Chest 130, 4S-12S.
5. Marceau, C., Lemière, C., Berbiche, D., Perreault, S. and Blais, L. (2006) Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma. J. Allergy Clin. Immunol. 118, 574-581.
6. Holgate, S.T. (2008) Pathogenesis of asthma. Clin. Exp. Allergy 38, 872-897.
7. Royce, S.G. and Tang, M.L (2009) The effects of current therapies on airway remodeling in asthma and new possibilities for treatment and prevention. Curr. Mol. Pharmacol. 2, 169-181.
8. Ge, X., Bai, C., Yang, J., Lou, G., Li, Q. and Chen, R. (2013) Effect of mesenchymal stem cells on inhibiting airway remodeling and airway inflammation in chronic asthma. J. Cell. Biochem. 114, 1595-1605.
9. Baraniak, P.R. and McDevitt, T.C. (2010) Stem cell paracrine actions and tissue regeneration. Regen. Med. 5, 121-143.
10. Weiss, D.J. (2014) Current status of stem cells and regenerative medicine in lung biology and diseases. Stem Cells 32, 16-25.
11. Royce, S.G., Moodley, Y. and Samuel, C.S. (2014) Novel therapeutic strategies for lung disorders associated with airway remodelling and fibrosis. Pharm. Therap. 141, 250-260.
12. Sun, Y.-Q., Deng, M.-X., He, J., Zeng, Q.-X., Wen, W., Wong, D.S.H., Tse, H.-F., Xu, G., Lian, Q., Shi, J. and Fu, Q.-L. (2012) Human pluripotent stem cell-derived mesenchymal stem cells prevent allergic airway inflammation in mice. Stem Cells 30, 2692-2699.
13. Moodley, Y., Ilancheran, S., Samuel, C., Vaghjiani, V., Atienza, D., Williams, E.D., Jenkin, G., Wallace, E., Trounson, A. and Manuelpillai, U. (2010) Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair. Am. J. Respir. Crit. Care Med. 182, 643-651.
14. Dolgachev, V.A., Ullenbruch, M.R., Lukacs, N.W. and Phan, S.H. (2009) Role of stem cell factor and bone marrow-derived fibroblasts in airway remodeling. Am. J. Path. 174, 390-400.
15. Knight, D.A. and Rossi, F.M. (2010) Mesenchymal stem cells for repair of the airway epithelium in asthma. Expert Rev. Respir. Med. 4, 747-758.
16. Samuel, C.S., Cendrawan, S., Gao, X.M., Ming, Z., Zhao, C., Kiriazis, H., Xu, Q., Tregear, G.W., Bathgate, R.A. and Du, X.J. (2011) Relaxin remodels fibrotic healing following myocardial infarction. Lab. Invest. 91, 675-690.
17. Teerlink, J.R., Cotter, G., Davison, B.A., Felker, G.M., Filippatos, G., Greenberg, B.H., Ponikowski, P., Unemori, E., Voors, A.A., Adams, Jr, K.F. et al. (2013) Serelaxin, recombinant relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381, 29-39.
18. Samuel, C.S., Hewitson, T.D., Unemori, E.N. and Tang, M.L. (2007) Drugs of the future: the hormone relaxin. Cell. Mol. Life Sci. 64, 1539-1557.
19. Unemori, E.N., Pickford, L.B., Salles, A.L., Piercy, C.E., Grove, B.H., Erikson, M.E. and Amento, E.P. (1996) Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J. Clin. Invest. 98, 2739-2745.
20. Kenyon, N.J., Ward, R.W. and Last, J.A. (2003) Airway fibrosis in a mouse model of airway inflammation. Toxicol. Appl. Pharmacol. 186, 90-100.
21. Tozzi, C.A., Poiani, G.J., McHugh, N. A., Shakarjian, M.P., Grove, B.H., Samuel, C.S., Unemori, E.N. and Riley, D.J. (2005) Recombinant human relaxin reduces hypoxic pulmonary hypertension in the rat. Pulm. Pharm. Therap. 18, 346-353.
22. Huang, X., Gai, Y., Yang, N., Lu, B., Samuel, C.S., Thannickal, V.J. and Zhou, Y. (2011) Relaxin regulates myofibroblast contractility and protects against lung fibrosis. Am. J. Path. 179, 2751-2765.
23. Royce, S.G., Miao, Y.R., Lee, M., Samuel, C.S., Tregear, G.W. and Tang, M.L. (2009) Relaxin reverses airway remodeling and airway dysfunction in allergic airways disease. Endocrinology 150, 2692-2699.
24. Royce, S.G., Lim, C.X., Patel, K.P., Wang, B., Samuel, C.S. and Tang, M.L. (2014) Intranasally administered serelaxin abrogates airway remodelling and attenuates airway hyperresponsiveness in allergic airways disease. Clin. Exp. Allergy 44, 1399-1408.
25. Huuskes, B.M., Wise, A.F., Cox, A.J., Lim, E.X., Payne, N.L., Kelly, D.J., Samuel, C.S. and Ricardo, S.D. (2015) Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy. FASEB J. 29, 540-553.
26. Royce, S.G., Shen, M., Patel, K.P., Huuskes, B.M., Ricardo, S.D. and Samuel, C.S. (2015) Mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease. Stem Cell Res 15, 495-505.
27. Akle, C.A., Adinolfi, M., Welsh, K.I., Leibowitz, S. and McColl, I. (1981) Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet 2, 1003-1005.
28. Miki, T., Lehmann, T., Cai, H., Stolz, D.B. and Strom, S.C. (2005) Stem cell characteristics of amniotic epithelial cells. Stem Cells 23, 1549-1559.
29. Murphy, S., Lim, R., Dickinson, H., Acharya, R., Rosli, S., Jenkin, G. and Wallace, E. (2011) Human amnion epithelial cells prevent bleomycin-induced lung injury and preserve lung function. Cell Transplant 20, 909-923.
30. Vosdoganes, P., Wallace, E.M., Chan, S.T., Acharya, R., Moss, T.J. and Lim, R. (2013) Human amnion epithelial cells repair established lung injury. Cell Transplant. 22, 1337-1349.
31. Temelkovski, J., Hogan, S.P., Shepherd, D.P., Foster, P.S. and Kumar, R.K. (1998) An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 53, 849-856.
32. Wise, A.F., Williams, T.M., Kiewiet, M.B., Payne, N.L., Siatskas, C., Samuel, C.S. and Ricardo, S.D. (2014) Human mesenchymal stem cells alter macrophage phenotype and promote regeneration via homing to the kidney following ischemia-reperfusion injury. Am. J. Physiol. Renal Physiol. 306, F1222-F1235.
33. Murphy, S., Rosli, S., Acharya, R., Mathias, L., Lim, R., Wallace, E. and Jenkin, G. (2010) Amnion epithelial cell isolation and characterization for clinical use. Curr. Prot. Stem Cell Biol.
34. Schneider, T., Osl, F., Friess, T., Stockinger, H. and Scheuer, W.V. (2002) Quantification of human Alu sequences by real-time PCR-an improved method to measure therapeutic efficacy of anti-metastatic drugs in human xenotransplants. Clin. Exp. Metastasis 19, 571-582.
35. Gallop, P.M. and Paz, M.A. (1975) Posttranslational protein modifications, with special attention to collagen and elastin. Physiol. Rev. 55, 418-487.
36. Giordano, N., Volpi, N., Franci, D., Corallo, C., Fioravanti, A., Papakostas, P., Montella, A., Biagioli, M., Fimiani, M., Grasso, G. et al. (2012) Expression of RXFP1 in skin of scleroderma patients and control subjects. Scand. J. Rheum. 41, 391-395.
37. Chen, H., Wu, S., Lu, R., Zhang, Y.G., Zheng, Y. and Sun, J. (2014) Pulmonary permeability assessed by fluorescent-labeled dextran instilled intranasally into mice with LPS-induced acute lung injury. PLoS One 9, e101925.
38. Bani, D., Ballati, L., Masini, E., Bigazzi, M. and Sacchi, T.B. (1997) Relaxin counteracts asthma-like reaction induced by inhaled antigen in sensitized guinea pigs. Endocrinology 138, 1909-1915.
39. Masini, E., Bani, D., Bigazzi, M., Mannaioni, P. F. and Bani-Sacchi, T. (1994) Effects of relaxin on mast cells. In vitro and in vivo studies in rats and guinea pigs. J. Clin. Invest. 94, 1974-1980.
40. Masini, E., Nistri, S., Vannacci, A., Bani Sacchi, T., Novelli, A. and Bani, D. (2004) Relaxin inhibits the activation of human neutrophils: involvement of the nitric oxide pathway. Endocrinology 145, 1106-1112.
41. Bani, D., Baronti, R., Vannacci, A., Bigazzi, M., Sacchi, T.B., Mannaioni, P.F. and Masini, E. (2002) Inhibitory effects of relaxin on human basophils activated by stimulation of the Fc epsilon receptor. The role of nitric oxide. Int. Immunopharmacol. 2, 1195-1204
42. Hirota, N. and Martin, J.G. (2013) Mechanisms of airway remodeling. Chest 144, 1026-1032.
43. Hogg, J.C. (1997) The pathology of asthma. APMIS 105, 735-745.
44. Firinci, F., Karaman, M., Baran, Y., Bagriyanik, A., Ayyildiz, Z.A., Kiray, M., Kozanoglu, I., Yilmaz, O., Uzuner, N. and Karaman, O. (2011) Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma. Int. Immunopharmacol. 11, 1120-1126.
45. Patel, K.P., Giraud, A.S., Samuel, C.S. and Royce, S.G. (2016) Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for allergic airways disease. Br. J. Pharmacol. 173, 2016-2029.
46. Bartemes, K.R. and Kita, H. (2012) Dynamic role of epithelium-derived cytokines in asthma. Clin. Immunol. 143, 222-235.
47. Linthout, S.V., Spillmann, F., Schultheiss, H.P. and Tschope, C. (2011) Effects of mesenchymal stromal cells on diabetic cardiomyopathy. Curr. Pharmaceut. Des. 17, 3341-3347.
48. Gillis, H.L. and Lutchen, K.R. (1999) Airway remodeling in asthma amplifies heterogeneities in smooth muscle shortening causing hyperresponsiveness. J. Appl. Physiol. 86, 2001-2012.
49. Weiss, D.J., Bertoncello, I., Borok, Z., Kim, C., Panoskaltsis-Mortari, A., Reynolds, S., Rojas, M., Stripp, B., Warburton, D. and Prockop, D.J. (2011) Stem cells and cell therapies in lung biology and lung diseases. Proc. Am. Thorac. Soc. 8, 223-272.
50. Weiss, D.J., Bertoncello, I., Borok, Z., Kim, C., Panoskaltsis-Mortari, A., Reynolds, S., Rojas, M., Stripp, B., Warburton, D. and Prockop, D.J. (2011) Stem cells and cell therapies in lung biology and lung diseases. Proc. Am. Thorac. Soc. 8, 223-272.
51. Weiss, D.J., Berberich, M.A., Borok, Z., Gail, D.B., Kolls, J.K., Penland, C. and Prockop, D.J. (2006) Adult stem cells, lung biology, and lung disease. NHLBI/Cystic Fibrosis Foundation Workshop. Proc. Am. Thorac. Soc. 3, 193-207.
52. Zhang, W.-G., He, L., Shi, X.-M., Wu, S.-S., Zhang, B., Mei, L., Xu, Y.-J., Zhang, Z.-X., Zhao, J.-P. and Zhang, H.-L. (2014) Regulation of transplanted mesenchymal stem cells by the lung progenitor niche in rats with chronic obstructive pulmonary disease. Respir. Res. 15, 33.
53. Moodley, Y., Vaghjiani, V., Chan, J., Baltic, S., Ryan, M., Tchongue, J., Samuel, C.S., Murthi, P., Parolini, O. and Manuelpillai, U. (2013) Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative study. PLoS One 8, e69299.
54. Ober, C. and Hoffjan, S. (2006) Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun. 7, 95-100.
55. Kariyawasam, H.H., Aizen, M., Barkans, J., Robinson, D.S. and Kay, A.B. (2007) Remodeling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma. Am. J. Respir. Crit. Care Med. 175, 896-904.
56. Boulet, L.P., Laviolette, M., Turcotte, H., Cartier, A., Dugas, M., Malo, J.L. and Boutet, M. (1997) Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine. Chest 112, 45-52.
57. Holgate, S.T., Holloway, J., Wilson, S., Bucchieri, F., Puddicombe, S. and Davies, D.E. (2004) Epithelial-mesenchymal communication in the pathogenesis of chronic asthma. Proc. Am. Thorac. Soc. 1, 93-98.
58. Ward, C., Johns, D.P., Bish, R., Pais, M., Reid, D.W., Ingram, C., Feltis, B. and Walters, E.H. (2001) Reduced airway distensibility, fixed airflow limitation, and airway wall remodeling in asthma. Am. J. Respir. Crit. Care Med. 164, 1718-1721.
59. Milanese, M., Crimi, E., Scordamaglia, A., Riccio, A., Pellegrino, R., Canonica, G.W. and Brusasco, V. (2001) On the functional consequences of bronchial basement membrane thickening. J. Appl. Physiol. 91, 1035-1040.